ArticleAnalytical and bioanalytical chemistry2026
Bacterial biomineralization-engineered Ag-Pt nanozyme for label-free and sensitive colorimetric detection of enrofloxacin in aquatic products.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The overuse of enrofloxacin (ENR) in aquaculture poses significant threats to ecological security and food safety, generating an urgent demand for instrument-free on-site detection. Herein, a Listeria-templated Ag-Pt bimetallic nanozyme (Listeria-Ag@Pt) was fabricated via a bacteria-templated in situ mineralization strategy. The intact bacterial template not only prevents nanoparticle aggregation to maximize peroxidase-like activity but also imparts inherent molecular recognition capability toward ENR without requiring antibodies or aptamers. The presence of ENR can enhance the catalytic efficiency of the nanozyme, significantly accelerating the oxidation of 3,3',5,5'-tetramethylbenzidine (TMB) by H
Indexed as
Identifiers
42671581What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.